Titanium Dioxide Nanoparticles as Radiosensitisers: An In vitro and Phantom-Based Study

Esho Qasho Youkhana1, Bryce Feltis2, Anton Blencowe3

  • 1Discipline of Medical Radiations, School of Health and Biomedical Sciences, RMIT University, Bundoora, Victoria, Australia.

Summary

Titanium dioxide nanoparticles (TiO2-NPs) enhance radiation dose delivery in cancer cells, showing potential for improved radiotherapy. These nanoparticles also exhibit theranostic capabilities, combining treatment and imaging.

Related Concept Videos